Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Sutton

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Gynecologic Oncology|June 18, 2013
Uterine sarcomas 2013Gregory Sutton
The Journal of Experimental Biology|August 26, 2011
An exemplar of energy accounting: the energetics of the locust jumpGregory Sutton
Science (New York, N.Y.)|September 14, 2013
Interacting gears synchronize propulsive leg movements in a jumping insectMalcolm Burrows, Gregory Sutton
Gynecologic Oncology|February 22, 2005
Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group studyGregory Sutton, John Blessing, Parviz Hanjani, et al.
Science (New York, N.Y.)|February 23, 2013
Detection and learning of floral electric fields by bumblebeesDominic Clarke, Heather Whitney, Gregory Sutton, et al.
Gynecologic Oncology|July 7, 2009
Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trialDaniela Matei, Jeanne Schilder, Gregory Sutton, et al.
Gynecologic Oncology|February 22, 2005
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group studyGregory Sutton, James Kauderer, Linda F Carson, et al.
Gynecologic Oncology|April 19, 2015
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229NVicky Makker, Virginia L Filiaci, Lee-May Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Presynaptic melanocortin-4 receptors on vagal afferent fibers modulate the excitability of rat nucleus tractus solitarius neuronsShuxia Wan, Kirsteen N Browning, F Holly Coleman, et al.
Gynecologic Oncology|October 11, 2005
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology GroupGregory Sutton, Janice H Axelrod, Brian N Bundy, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology|June 18, 2013
Uterine sarcomas 2013Gregory Sutton
The Journal of Experimental Biology|August 26, 2011
An exemplar of energy accounting: the energetics of the locust jumpGregory Sutton
Science (New York, N.Y.)|September 14, 2013
Interacting gears synchronize propulsive leg movements in a jumping insectMalcolm Burrows, Gregory Sutton
Gynecologic Oncology|February 22, 2005
Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a Gynecologic Oncology Group studyGregory Sutton, John Blessing, Parviz Hanjani, et al.
Science (New York, N.Y.)|February 23, 2013
Detection and learning of floral electric fields by bumblebeesDominic Clarke, Heather Whitney, Gregory Sutton, et al.
Gynecologic Oncology|July 7, 2009
Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trialDaniela Matei, Jeanne Schilder, Gregory Sutton, et al.
Gynecologic Oncology|February 22, 2005
Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group studyGregory Sutton, James Kauderer, Linda F Carson, et al.
Gynecologic Oncology|April 19, 2015
Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor fusion protein, for the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study 0229NVicky Makker, Virginia L Filiaci, Lee-May Chen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2008
Presynaptic melanocortin-4 receptors on vagal afferent fibers modulate the excitability of rat nucleus tractus solitarius neuronsShuxia Wan, Kirsteen N Browning, F Holly Coleman, et al.
Gynecologic Oncology|October 11, 2005
Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology GroupGregory Sutton, Janice H Axelrod, Brian N Bundy, et al.
Pageof 2